HMG20A: A Potential Drug Target and Biomarker (G10363)

Target Name: HMG20A

NCBI ID: G10363

HMG20A: A Potential Drug Target and Biomarker

HMG20A, also known as FLJ10739, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell proliferation and has been identified as a potential drug target in the treatment of various diseases, including cancer.

HMG20A plays a crucial role in the regulation of cell growth and division. It is a key regulator of the DNA replication process, which is essential for cell growth and development. In addition, HMG20A is involved in the regulation of cell apoptosis, which is the process by which cells are programmed to die.

HMG20A has been shown to be a potential drug target in the treatment of various diseases, including cancer. For example, studies have shown that inhibiting HMG20A has been effective in treating cancer cells. This is because HMG20A plays a role in the regulation of cell proliferation, which is a key factor in the development and progression of cancer.

Another potential use of HMG20A as a drug target is its role in the regulation of pain. HMG20A has been shown to be involved in the regulation of pain signaling, which means that it may be a useful target for the treatment of chronic pain.

In addition to its potential as a drug target, HMG20A is also a potential biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that HMG20A levels are often elevated in cancer cells, which may be a useful indicator for the diagnosis of cancer.

Overall, HMG20A is a protein that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in the regulation of cell proliferation and other processes, as well as its potential as a treatment for various diseases.

Protein Name: High Mobility Group 20A

Functions: Plays a role in neuronal differentiation as chromatin-associated protein. Acts as inhibitor of HMG20B. Overcomes the repressive effects of the neuronal silencer REST and induces the activation of neuronal-specific genes. Involved in the recruitment of the histone methyltransferase KMT2A/MLL1 and consequent increased methylation of histone H3 lysine 4 (By similarity)

More Common Targets